(INNS)
VOPRATELIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS ICOS (INDUCTIBLE T-CELL COSTIMULATORY, ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE, AILIM, CD278)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-447) [HUMANIZED VH (IGHV3-74*01 (88.8%) -(IGHD) -IGHJ5*01 (100%)) [8.8.10] (1-117) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (214) (118-215), HINGE (216-230), CH2 (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-447)) (118-447)], (220-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') [HUMANIZED V-KAPPA (IGKV4-1*01 (84.2%) -IGKJ3*01 (100%)) [10.3.9] (1'-111') -HOMO SAPIENS IGKC*01, KM3 A45.1 (157), V101 (195) (112'-218')]; DIMER (226-226'':229-229'')-BISDISULFIDE. RECOMMENDED INN: LIST 80(WHO)
VOPRATELIMABUM(INN)